COMMUNIQUÉS West-GlobeNewswire

Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]
89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress
22/05/2024
-Poster presentation selected for the EASL Poster Tour, a dedicated discussion session- SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on [...]
BrightSpring Health Services, Inc. to Participate in Three Upcoming Investor Conferences
22/05/2024
LOUISVILLE, Ky., May 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that Company management will participate at three upcoming investor [...]
Nyxoah Announces Proposed Offering of Ordinary Shares
22/05/2024
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – May 22, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” [...]
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
22/05/2024
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires Mont-Saint-Guibert, Belgique – 22 mai 2024, 22h05 CET / 16h05 ET - Nyxoah SA (Euronext Brussels/Nasdaq : [...]
Cytokinetics Announces Proposed Public Offering of Common Stock
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced plans to offer, subject to market and other conditions, approximately $500 million of shares of its [...]
Standard BioTools to Participate in Upcoming Investor Conferences
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools”) (Nasdaq:LAB) today announced that its management team will participate in the following investor conferences in [...]
Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
22/05/2024
Deal Provides Cytokinetics with Diversified Access to Capital as Company Advances Its Specialty Cardiology Franchise SOUTH SAN FRANCISCO, Calif. and NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated [...]
Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024
22/05/2024
The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in patients with MASH/ [...]
Inventiva annonce deux présentations scientifiques lors de l’EASL International Liver Congress™ 2024
22/05/2024
Le premier abstract démontre un parallèle entre les améliorations du score MACK-3, un test de diagnostic de la stéatohépatite associée à un dysfonctionnement métabolique, et la réponse histologique au traitement par [...]
Media Conference - Update: Fightback to Save Durham Hospital Ratcheting Up
22/05/2024
TORONTO and GREY BRUCE, Ontario, May 22, 2024 (GLOBE NEWSWIRE) -- It is a small community, but it has raised its voice for the whole province to hear. Almost a thousand community members have taken to the streets in [...]
Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy
22/05/2024
MUHARRAQ, Bahrain, May 22, 2024 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has achieved a significant milestone, becoming amongst the first centres in the World to offer the ground-breaking CASGEVY ( [...]
Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
22/05/2024
ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to [...]
ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine
22/05/2024
La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT ONWARD Medical présentera les résultats de cet essai pivot à l’occasion d’une téléconférence organisée cette semaine avec le concours de [...]
SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024
22/05/2024
SOHM, Inc. Further Advances its Work in the Field of Genome Editing and ABBIE, a Retroviral Integrase with Linked Guided DNA Binding Domain CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. ( [...]
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
22/05/2024
Quorum of 27.25% on first convening; allowing approval of all the resolutions Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 22, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late- [...]
GENFIT : Résultats de l’Assemblée Générale Mixte du 22 mai 2024
22/05/2024
Quorum de 27,25% obtenu sur première convocation ayant permis d’approuver l’ensemble des projets de résolutions Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 22 mai 2024 – GENFIT (Nasdaq et [...]
Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials
22/05/2024
WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials . This new offering expands [...]
Guerbet : NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre.
22/05/2024
COMMUNIQUE DE PRESSE NUCLIDIUM et Guerbet concluent un partenariat stratégique pour soutenir le développement de la radiothéranostique ciblée basée sur des radio-isotopes de cuivre L'accord allie l'expertise de pointe [...]

Pages